Skip to content

Using of Acellular Dermal Matrix in Cleft Palatal Fistula and Compare With Use of Conchal Cartolage

Using of Acellular Dermal Matrix in Cleft Palatal Fistula and Compare With Use of Conchal Cartolage

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03170505
Enrollment
60
Registered
2017-05-31
Start date
2015-05-27
Completion date
2017-05-27
Last updated
2017-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cleft Palate

Keywords

cleft palate

Brief summary

The fact that still exist is which method for repairing of secondary cleft palatal fistula is the best. This study will have shown whether using of Acellular dermal Matrix decreased the fistula formation versus using Conchal Cartilage during secondary fistula. Among studies that published, they have not consensus for using acellular dermal matrix. Most of the questions are about cost effectiveness, time that surgery and rehabilitation need and patient risk ( risk of transmission disease from other human tissue )

Detailed description

Observational study composed of a prospective cohort group receiving ADM compared to a retrospective historical cohort group with Conchal Cartilage. Primary objectives: The primary objective of this study is to determine whether ADM would lower the incidence of palatal fistula in patients undergoing secondary cleft palate fistula repair. Secondary objectives: 1. hypo nasality speech after surgery 2. Improvement Speech Score

Interventions

PROCEDURErepairing fistula

A tailored piece of Acellular Dermal Matrix or Conchal Cartilage will be placed between the oral and nasal layers for repair of a Cleft Palate.

Sponsors

Isfahan University of Medical Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Patients diagnosed as having cleft palate fistula, with ADM will be included in this study.

Exclusion criteria

* Selection will be based on the patient's willingness to allow to participate in the study. * Patients with diagnosed craniofacial syndromes will be excluded from the study. * Children with known wound healing defects, will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Fistula formationWithin 2 year of surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026